
Fobidime-TZ 1.125gm Injection
Marketer
Forgo Pharmaceuticals Pvt Ltd
Salt Composition
Ceftazidime (1000mg) + Tazobactum (125mg)
Overview Fobidime-TZ 1.125gm Injection
Ceftazidime/Tazobactam 1.125g injection is a dual-action antibiotic prescribed for diverse bacterial infections. It combats microorganisms, inhibiting their proliferation and infection spread. Administration must be solely under a doctor's guidance; adhere strictly to the prescribed schedule. Complete the entire treatment course, even with symptom improvement; premature cessation may reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects immediately. Seek urgent medical attention for allergic reactions (rash, itching, swelling, dyspnea). Inform your physician of all concurrent medications, particularly if pregnant or breastfeeding. Alcohol should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, a balanced diet, and sufficient hydration are crucial for optimal recovery. Your doctor might order lab tests to monitor the medicine's impact.
Uses of Fobidime-TZ 1.125gm Injection
Infections caused by bacteria
Major Benefits of Fobidime-TZ 1.125gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Fobidime-TZ 1.125gm Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Fobidime-TZ 1.125gm Injection:
Administering this medication will be performed by your doctor or nurse; self-medication is strictly prohibited.
How Fobidime-TZ 1.125gm Injection works:
Fobidime-TZ 1.125gm Injection unites Ceftazidime, a crucial antibiotic, with Tazobactam, a beta-lactamase inhibitor. Ceftazidime's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Tazobactam counters bacterial resistance mechanisms, thereby boosting Ceftazidime's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Fobidime-TZ 1.125gm Injection may be consumed concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation Fobidime-TZ (1.125 gm) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or absent harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Fobidime-TZ (1.125 gm) poses no known breastfeeding safety risk. Research in humans indicates minimal drug transfer to breast milk, presenting no apparent danger to infants.
DrivingUNSAFE
The administration of Fobidime-TZ 1.125gm Injection can potentially reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCAUTION
The injectable formulation of Fobidime-TZ (1.125gm) requires careful administration for individuals with impaired renal function. Dosage modification for Fobidime-TZ (1.125gm) injection may be necessary. Physician consultation is advised.
LiverCAUTION
The administration of Fobidime-TZ 1.125gm Injection requires careful consideration in individuals exhibiting severe hepatic impairment. Dosage modification of Fobidime-TZ 1.125gm Injection might be necessary. Physician consultation is advised.
What if you forget to take Fobidime-TZ 1.125gm Injection :
Omitting a scheduled dose of Fobidime-TZ 1.125gm Injection necessitates contacting your physician.
Facts to Know About Fobidime-TZ 1.125gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
